Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1696
interventional 1028
Observational 594
Registry 74

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 271
Device 200
Drug|placebo 115
Behavioral 96
Procedure 92
Other 85
Diagnostic Test 19
Drug|Procedure 15
Dietary Supplement 13
Behavioral|Other 12
Behavioral|Drug 11
Biological 8
Biological|placebo 8
Device|Drug 8
Dietary Supplement|placebo 8
Device|Other 7
Other|Procedure 6
Device|Procedure 5
Drug|Other 5
Drug|Other|placebo 5
Behavioral|Device 4
Radiation 4
Behavioral|Drug|Other 3
Behavioral|Procedure 2
Other|placebo 2
placebo|Procedure 2
Behavioral|Biological|Drug 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Drug|placebo 1
Behavioral|Drug|Procedure 1
Behavioral|Genetic 1
Behavioral|Genetic|Other 1
Biological|Other 1
Biological|Other|placebo 1
Combination Product 1
Device|Drug|placebo 1
Device|Drug|Procedure 1
Device|Other|Procedure 1
Device|placebo 1
Diagnostic Test|Other 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Other 1
Drug|Genetic 1
Drug|placebo|Radiation 1
Drug|Procedure|Radiation 1
Genetic|placebo 1
placebo 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 234
NA 138
China 75
Germany 57
Canada 46
Korea, Republic of 36
United Kingdom 36
Japan 31
Brazil 27
France 23
Switzerland 21
Italy 20
Norway 18
Denmark 17
Netherlands 17
Poland 11
Sweden 11
Belgium 10
India 9
Finland 8
Greece 8
Spain 7
United States|Canada 7
Taiwan 6
Russian Federation 5
Australia 4
Austria 4
Iran, Islamic Republic of 4
Israel 4
Egypt 3
Portugal 3
Slovenia 3
Belgium|Netherlands 2
Colombia|Italy 2
Czech Republic 2
Germany|Italy 2
Hong Kong 2
Hungary 2
Jordan 2
Pakistan 2
United States|Australia 2
United States|Ireland|Netherlands|Sweden 2
United States|United Kingdom 2
Argentina 1
Australia|Belgium|Brazil|Germany|Netherlands|New Zealand|Poland|Switzerland 1
Australia|Belgium|Denmark|France|Germany|Netherlands|New Zealand|Portugal|Switzerland|United Kingdom 1
Australia|Belgium|Denmark|France|Netherlands|New Zealand|Poland|Switzerland 1
Australia|Belgium|New Zealand 1
Australia|France|Netherlands|Sweden|United Kingdom 1
Australia|Malaysia|New Zealand|Singapore 1
Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Austria|Belgium|Czech Republic|Denmark|Germany|Lithuania|Netherlands|Poland|Romania|Sweden|Switzerland 1
Austria|Belgium|Denmark|France|Germany|India|Italy|Netherlands|New Zealand|Poland|South Africa|Spain|Switzerland 1
Austria|Belgium|United States|Argentina|Australia|Brazil|Canada|China|Czechia|Denmark|Finland|France|Germany|Grenada|Hungary|Ireland|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Puerto Rico|Slovakia|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Czechia|Denmark|Germany|Hungary|Ireland|Italy|Latvia|Lithuania|Poland|Portugal|Romania|Serbia|Spain|United Kingdom 1
Austria|Denmark|France|Germany|Greece|Netherlands|Portugal|Spain 1
Austria|Denmark|Germany|Hungary|Switzerland 1
Austria|Denmark|Germany|Switzerland 1
Austria|France|Germany|Israel|Italy|Malaysia|Netherlands|Poland|Spain|Thailand|United Kingdom 1
Austria|France|Germany|Italy|Netherlands|Switzerland|United Kingdom 1
Austria|Germany|Switzerland 1
Austria|Hungary 1
Belgium|Brazil|Czechia|Latvia|Macedonia, The Former Yugoslav Republic of|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Brazil|Denmark|Germany|Netherlands|Singapore|Spain|Switzerland 1
Belgium|Brazil|Denmark|Germany|New Zealand|Poland 1
Belgium|Czech Republic|France|Germany|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|France|Germany|Netherlands|Poland|Switzerland|United Kingdom 1
Belgium|France|Luxembourg|Netherlands 1
Belgium|France|Netherlands|New Zealand|Sweden|United Kingdom 1
Belgium|Germany|Netherlands|Switzerland 1
Belgium|New Zealand 1
Brazil|Bulgaria|France|Italy|Netherlands|Poland|Spain 1
Brazil|Germany|Netherlands 1
Brazil|Indonesia|Macedonia, The Former Yugoslav Republic of|Malaysia 1
Bulgaria|United States|Argentina|Australia|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
Canada|New Zealand 1
Chile 1
China|Hong Kong 1
China|Korea, Republic of 1
Colombia 1
Denmark|Finland|Latvia|Sweden 1
Denmark|Finland|Sweden 1
Denmark|France|Germany|Italy|Japan|Lithuania|Netherlands|Poland|Spain|Sweden|Switzerland 1
Denmark|Netherlands|Spain 1
Denmark|Netherlands|Spain|Sweden 1
Denmark|Poland 1
Denmark|Sweden 1
France|Germany|Italy|Netherlands 1
France|Germany|Italy|Serbia|Spain 1
France|Germany|Italy|Spain|Switzerland 1
France|Germany|Netherlands 1
Germany|Moldova, Republic of|Netherlands 1
Hong Kong|Taiwan 1
Indonesia 1
Ireland 1
Ireland|Austria|Belgium|Canada|China|Czech Republic|France|Germany|Greece|India|Israel|Italy|Malaysia|Netherlands|New Zealand|Portugal|Singapore|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
Israel|Netherlands|South Africa|United States|Belgium|Denmark|United Kingdom 1
Italy|United Kingdom 1
Japan|Philippines 1
Japan|Poland|Portugal|Ukraine|United States|Argentina|Australia|Brazil|Bulgaria|Canada|China|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|United Kingdom 1
Latvia 1
Lebanon 1
Mexico 1
Netherlands|Spain 1
Norway|United States|Australia|Belgium|Canada|Czechia|Denmark|France|Hungary|Korea, Republic of|Lithuania|Netherlands|New Zealand|Serbia|Sweden|United Kingdom 1
Palestinian Territory, occupied 1
Poland|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Denmark|France|Germany|India|Israel|Italy|Japan|Malaysia|Netherlands|New Zealand|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
Romania 1
Spain|United States|Australia|Austria|Belgium|Canada|France|Germany|Ireland|Italy|Netherlands|South Africa|Switzerland|United Kingdom| 1
Trinidad and Tobago 1
Tunisia 1
Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Croatia|Czech Republic|Estonia|Finland|France|Germany|Greece|India|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Egypt|France|Germany|Hungary|India|Israel|Italy|Japan|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|North Macedonia|Peru|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Hungary|Italy|Poland|Spain 1
United States|Argentina|Australia|Bulgaria|Canada|Denmark|Estonia|France|Germany|Hungary|India|Netherlands|New Zealand|Pakistan|Romania|Spain 1
United States|Argentina|Austria|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Thailand|Turkey 1
United States|Argentina|Brazil|Chile|Colombia|Lithuania|Netherlands|Peru|Venezuela 1
United States|Argentina|Peru|Puerto Rico 1
United States|Australia|Canada|China|Czech Republic|Denmark|France|Hungary|Mexico|Netherlands|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Germany 1
United States|Australia|Canada|Singapore 1
United States|Australia|Czechia|Germany|Hungary|Italy|Netherlands 1
United States|Australia|Germany|New Zealand 1
United States|Belarus|Bulgaria|Canada|Czech Republic|Georgia|Germany|Israel|Poland|Russian Federation|Serbia|Slovakia|Slovenia|Ukraine 1
United States|Belgium|Bulgaria|Canada|Czech Republic|Denmark|Finland|France|Georgia|Germany|Hungary|India|Ireland|Italy|Korea, Republic of|Netherlands|Norway|Poland|Romania|Russian Federation|Spain|Sweden|Ukraine|United Kingdom 1
United States|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Netherlands|Serbia|Sweden|United Kingdom 1
United States|Belgium|Canada|Japan|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Belgium|Canada|Netherlands|Poland|Spain 1
United States|Brazil|Canada|Denmark|Germany|Japan|Netherlands|Singapore 1
United States|Brazil|India|Italy|Korea, Republic of|Poland 1
United States|Canada|Czech Republic|Germany|Hungary|New Zealand|Norway|Slovakia|South Africa 1
United States|Canada|Czech Republic|Germany|South Africa|United Kingdom 1
United States|Canada|Denmark 1
United States|Canada|Denmark|Netherlands|Singapore|Sweden|United Kingdom 1
United States|Canada|Denmark|United Kingdom 1
United States|Canada|Finland|France|Germany|Netherlands 1
United States|Canada|Finland|Puerto Rico 1
United States|Canada|Germany|United Kingdom 1
United States|Colombia 1
United States|Czechia|Netherlands|United Kingdom 1
United States|Denmark|Germany|Israel|Netherlands 1
United States|France|Germany|Korea, Republic of|New Zealand|Switzerland|United Kingdom 1
United States|Germany 1
United States|Ukraine 1
Venezuela 1

Sites per Study

Site_count Study_Count
1 732
2 61
3 26
4 17
5 18
6 12
7 11
8 8
9 11
10 12
11 5
12 9
13 9
14 3
15 5
16 5
17 6
18 2
19 3
20 4
23 4
24 2
25 3
27 2
28 4
29 2
30 1
32 2
33 2
34 3
36 2
38 2
39 1
41 2
44 1
45 1
46 2
48 1
49 1
52 1
56 1
58 1
59 1
62 2
69 1
73 1
81 1
92 1
93 1
112 1
119 1
120 1
122 1
124 1
128 1
135 1
144 1
147 1
150 1
154 1
167 1
177 1
195 1
241 1
314 1
320 1
471 1
578 1
1091 1

Phase

Phase Study_Count
N/A 432
Phase 4 203
Phase 3 191
Phase 2 127
Phase 1 34
Phase 2/Phase 3 25
Phase 1/Phase 2 11
Early Phase 1 5

Number of Arms

Number_of_Arms Count_of_Studies
1 152
2 553
3 93
4 42
5 4
6 12
8 2
11 1
NA 169

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20.0 3.0000 10.0000 20.0000 2.0000 29.00 25.000 12.00
1st Qu. 22.0 54.5000 20.0000 27.0000 34.5000 59.00 123.000 60.00
Median 38.0 123.0000 32.0000 50.0000 90.0000 150.00 372.000 210.00
Mean 44.2 503.0422 306.2941 163.5455 271.5042 507.04 1743.129 811.01
3rd Qu. 49.0 428.5000 70.0000 208.5000 183.5000 380.00 797.500 650.00
Max. 92.0 11700.0000 8400.0000 643.0000 10000.0000 4000.00 39876.000 22000.00

Trial Group Type

group_type Group_Count
Experimental 838
Active Comparator 581
Placebo Comparator 172
NA 169
No Intervention 120
Other 103
Sham Comparator 10

Intervention Model

intervention_model Study_Count
Parallel Assignment 646
Single Group Assignment 205
NA 73
Crossover Assignment 68
Factorial Assignment 29
Sequential Assignment 7

Primary Purpose

primary_purpose Study_Count
Treatment 621
Prevention 158
Diagnostic 118
Basic Science 38
Supportive Care 25
NA 21
Other 20
Health Services Research 17
Screening 9
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
NA 246
United States 96
Germany 30
China 26
Korea, Republic of 20
United Kingdom 18
Italy 13
France 11
Canada 10
Norway 10
Switzerland 8
Netherlands 7
Denmark 6
Poland 6
Austria 5
Belgium 5
Greece 5
Russian Federation 5
Sweden 5
Brazil 4
Finland 4
India 4
Japan 4
Israel 3
Singapore 3
Taiwan 3
Turkey 3
Croatia 2
Mexico 2
United States|Denmark 2
Australia 1
Austria|Belgium|Denmark|France|Germany|Hungary|Ireland|Italy|Netherlands|Spain|United Kingdom 1
Austria|Germany 1
Austria|Russian Federation|Uzbekistan 1
Bangladesh 1
Belgium|France|Germany|Hungary|Ireland|Italy|Latvia|Poland|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Switzerland 1
Belgium|Germany|Italy|Switzerland 1
China|India|Malaysia|Sri Lanka|Vietnam 1
Denmark|France|Germany|Italy|Japan|Netherlands|United Kingdom 1
Denmark|Netherlands|New Zealand|Poland 1
Egypt 1
Germany|Italy|Portugal|Spain 1
Germany|United Kingdom 1
Hong Kong 1
Iran, Islamic Republic of 1
Italy|Austria|Belgium|Bulgaria|Germany|Netherlands|Poland|Switzerland|United Kingdom 1
Qatar 1
Romania 1
Slovenia 1
Spain 1
Spain|Sweden 1
Spain|United States|Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Sweden|Switzerland|United Kingdom 1
Trinidad and Tobago 1
United States|Austria|Canada|Germany|Italy|Korea, Republic of|Switzerland 1
United States|Canada 1
United States|Canada|Puerto Rico 1
United States|Saudi Arabia 1

Sites per Study

Site_count Study_Count
1 491
2 24
3 6
4 8
5 6
6 8
7 3
8 4
9 3
10 4
11 1
12 1
13 2
14 1
17 1
18 2
19 2
20 2
23 4
24 2
25 1
29 2
32 1
33 1
37 1
38 1
40 3
43 1
47 1
50 2
58 1
81 1
90 1
107 1
183 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 124.00
Median 490.50
Mean 15693.91
3rd Qu 2000.00
Max 1758584.00

Observation Model

observational_model Study_Count
Cohort 248
NA 212
Case-Only 47
Other 27
Case Control 25
Case-Control 21
Case-Crossover 3
Family-Based 3
Defined Population 2
Defined Population, Natural History 2
Natural History 2
Case Control, Natural History 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 283
NA 179
Retrospective 66
Cross-Sectional 54
Other 6
Longitudinal, Prospective 4
Cross-Sectional, Prospective 1
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
China 15
Korea, Republic of 8
United States 5
Belgium 4
Germany 3
Greece 3
Italy 3
NA 3
Russian Federation 3
Spain 3
Brazil 2
France 2
Netherlands 2
Belgium|Hong Kong 1
Belgium|Netherlands 1
Colombia 1
Denmark 1
Finland 1
France|Germany|Switzerland 1
Japan 1
Netherlands|Russian Federation 1
Norway 1
Portugal 1
Singapore 1
Thailand 1
Tunisia 1
Turkey 1
United Kingdom 1
United States|Argentina|Canada|India|Italy 1
United States|Canada|Germany|Israel 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 48
2 4
3 1
4 3
5 1
6 2
7 2
9 1
11 1
13 1
14 1
16 3
18 1
20 1
21 1
24 1
28 1
37 1

Enrollment Metrics

Measure Registries
Min 11.0
1st Qu 300.0
Median 1042.5
Mean 100382.4
3rd Qu 2000.0
Max 7205000.0

Registry Model

observational_model Study_Count
Cohort 57
Case-Only 8
Other 7
Case-Control 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 67
Other 5
Cross-Sectional 1
NA 1

Follow-up

target_duration Study_Count
5 Years 15
12 Months 14
1 Year 10
2 Years 7
1 Day 6
3 Years 6
24 Months 5
10 Years 3
6 Months 2
1 Week 1
15 Years 1
18 Months 1
3 Days 1
3 Months 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04138238 Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent https://ClinicalTrials.gov/show/NCT04138238 Recruiting Sahajanand Medical Technologies Pvt. Ltd. 2021-11-30
NCT03373552 Genetic Polymorphism Contributing to the Variability of Clopidogrel Response in Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03373552 Recruiting Hôpital Universitaire Fattouma Bourguiba 2019-11-15
NCT03479580 Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry https://ClinicalTrials.gov/show/NCT03479580 Recruiting University Hospital, Grenoble 2028-02-29
NCT03824600 Physiological Patterns of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03824600 Completed Onze Lieve Vrouw Hospital 2019-08-30
NCT03315234 Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03315234 Active, not recruiting Aristotle University Of Thessaloniki 2018-06-30
NCT03151018 Effect and Efficacy of Onyxâ„¢, Zotarolimus-eluting Stent for Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT03151018 Recruiting Seoul National University Hospital 2018-05-31
NCT03150680 Development of a Risk Prediction Algorithm Through the Investigation of Genetic Risk Factors and the Complexity of Coronary Artery Disease to Estimate Future Risk of Cardiovascular Events: Angiographic (SYNTAX Score), Clinical and Pharmacogenetic Analysis. https://ClinicalTrials.gov/show/NCT03150680 Recruiting AHEPA University Hospital 2020-02-29
NCT03066141 Evaluation of Association Between Obstructive Sleep Apnea and the Severity of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT03066141 Completed Chinese Pulmonary Vascular Disease Research Group 2019-08-29
NCT03051061 Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03051061 Recruiting Henan Institute of Cardiovascular Epidemiology 2019-12-01
NCT03045913 Genoss DES Prospective Multicenter Registry https://ClinicalTrials.gov/show/NCT03045913 Recruiting Yonsei University 2019-12-31
NCT03045848 Biofreedom Prospective Multicenter Observational Registry https://ClinicalTrials.gov/show/NCT03045848 Recruiting Wonju Severance Christian Hospital 2020-06-30
NCT02996903 Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017 https://ClinicalTrials.gov/show/NCT02996903 Completed Klinikum der Universitaet Muenchen 2017-10-31
NCT02996877 Outcomes of Surgically Ineligible Patients With Multivessel CAD https://ClinicalTrials.gov/show/NCT02996877 Active, not recruiting Saint Luke’s Health System 2020-06-30
NCT02888652 Study on the Registration of Coronary Heart Disease Patients Undergoing PCI https://ClinicalTrials.gov/show/NCT02888652 Completed The Third Xiangya Hospital of Central South University 2018-08-31
NCT02854813 Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02854813 Completed Ankara Training and Research Hospital 2017-01-31
NCT02845804 Effect and Efficacy of Xpeditionâ„¢/Alpineâ„¢, Everolimus-eluting Stent for Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT02845804 Recruiting Seoul National University Hospital 2018-07-31
NCT02817802 BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV https://ClinicalTrials.gov/show/NCT02817802 Recruiting Biotronik AG 2020-10-31
NCT02803411 Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM) https://ClinicalTrials.gov/show/NCT02803411 Active, not recruiting Yonsei University 2026-01-31
NCT02751060 Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease https://ClinicalTrials.gov/show/NCT02751060 Enrolling by invitation Tongji Hospital 2019-12-31
NCT02635230 What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. https://ClinicalTrials.gov/show/NCT02635230 Recruiting R&D Cardiologie 2021-01-31
NCT02440646 Natural History of Atherosclerosis in Real-World Patients Underwent Computed Tomography Angiography https://ClinicalTrials.gov/show/NCT02440646 Enrolling by invitation Ural Medical University 2016-12-31
NCT02410330 Therapeutic Use of Ultrasound in Acute Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02410330 Completed University of Sao Paulo General Hospital 2020-01-31
NCT02364778 Single-centre, Registry Trial, the Patients Presented With Stable Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02364778 Completed Icahn School of Medicine at Mount Sinai 2015-05-31
NCT02313038 Prospective Assessment of Efficacy and Safety of Drug Eluting Stents https://ClinicalTrials.gov/show/NCT02313038 Completed China National Center for Cardiovascular Diseases 2015-07-31
NCT02281110 The REAL Registry for Utilization of iFR in Assessing Coronary Stenoses https://ClinicalTrials.gov/show/NCT02281110 Completed Volcano Corporation 2015-12-31
NCT02247492 BIOFLOW-III VIP Russia Registry Orsiro Stent System https://ClinicalTrials.gov/show/NCT02247492 Recruiting Biotronik Russia 2019-04-30
NCT02237456 DOCTOR Compare - A Study in the “DOCTOR” Series (Does Optical Coherence Tomography Optimize Revascularization?" https://ClinicalTrials.gov/show/NCT02237456 Completed Aarhus University Hospital Skejby 2014-09-30
NCT02180178 Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registery https://ClinicalTrials.gov/show/NCT02180178 Recruiting Johannes Gutenberg University Mainz 2020-09-30
NCT02186093 Clinical, Physiological and Prognostic Implication of Microvascular Status https://ClinicalTrials.gov/show/NCT02186093 Recruiting Seoul National University Hospital 2020-11-30
NCT02173067 Anesthesia With Epinephrine in Diabetes Patients is Safe and Effective https://ClinicalTrials.gov/show/NCT02173067 Completed University of Sao Paulo General Hospital 2012-11-30
NCT02026466 Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion https://ClinicalTrials.gov/show/NCT02026466 Completed Saint Luke’s Health System 2017-09-30
NCT02029092 BIOFLOW III Satellite-ELADIS Orsiro Stent System https://ClinicalTrials.gov/show/NCT02029092 Completed C.E.M. Biotronik, S.A. 2016-07-31
NCT02028728 BIOFLOW III Satellite-Italy Orsiro Stent System https://ClinicalTrials.gov/show/NCT02028728 Completed Biotronik Italia S.p.A. 2016-07-31
NCT02018497 Essential Hypotension and Allostasis Registry https://ClinicalTrials.gov/show/NCT02018497 Recruiting CES University 2020-07-30
NCT01977534 To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels https://ClinicalTrials.gov/show/NCT01977534 Completed Abbott Medical Devices 2018-10-31
NCT01917682 Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions https://ClinicalTrials.gov/show/NCT01917682 Completed Corindus Inc. 2016-12-31
NCT01873560 Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT01873560 Completed Inje University 2016-06-30
NCT01856504 Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY https://ClinicalTrials.gov/show/NCT01856504 Completed MDDX LLC 2015-03-31
NCT01850693 Assessment of Coronary Artery Disease in Stroke Patients https://ClinicalTrials.gov/show/NCT01850693 Completed Seoul National University Hospital 2012-12-31
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease https://ClinicalTrials.gov/show/NCT01835808 Completed Portuguese Society of Cardiology 2013-11-30
NCT01808391 A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL) https://ClinicalTrials.gov/show/NCT01808391 Completed Associations for Establishment of Evidence in Interventions 2014-05-31
NCT01787370 Mainz Registry of Flow-mediated Constriction https://ClinicalTrials.gov/show/NCT01787370 Completed Johannes Gutenberg University Mainz 2018-02-01
NCT01788592 Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry) https://ClinicalTrials.gov/show/NCT01788592 Recruiting Asan Medical Center 2030-10-31
NCT01759290 ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients. https://ClinicalTrials.gov/show/NCT01759290 Completed Abbott Medical Devices 2015-08-31
NCT03349385 Registry of Secondary Revascularization https://ClinicalTrials.gov/show/NCT03349385 Active, not recruiting Hospital San Carlos, Madrid 2021-01-15
NCT04444960 Precision Therapy in Complex High-risk Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04444960 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2023-06-30
NCT04347200 REGistry of Long-term AnTithrombotic TherApy-1 https://ClinicalTrials.gov/show/NCT04347200 Recruiting National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 2025-12-31
NCT04255563 Drug-coating Balloon Treatment in Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04255563 Recruiting Nanjing First Hospital, Nanjing Medical University 2030-12-30
NCT04234893 Bingo Drug-Coated Balloon in Real World https://ClinicalTrials.gov/show/NCT04234893 Recruiting Yinyi(Liaoning) Biotech Co., Ltd. 2022-09-30
NCT04196712 Essen Coronary Artery Disease Registry https://ClinicalTrials.gov/show/NCT04196712 Recruiting University Hospital, Essen 2022-12-30
NCT04185493 Coronary Artery Geometry and the Severity of Coronary Atherosclerosis https://ClinicalTrials.gov/show/NCT04185493 Recruiting Aristotle University Of Thessaloniki 2021-06-30
NCT04162561 TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes (ALIGN) https://ClinicalTrials.gov/show/NCT04162561 Active, not recruiting National Research Center for Preventive Medicine 2022-12-31
NCT04022200 Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions https://ClinicalTrials.gov/show/NCT04022200 Recruiting Beijing Hospital 2023-01-31
NCT04012281 International Post PCI FFR Registry https://ClinicalTrials.gov/show/NCT04012281 Completed Seoul National University Hospital 2019-02-11
NCT04009421 Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease https://ClinicalTrials.gov/show/NCT04009421 Active, not recruiting University of Bergen 2022-01-31
NCT03890822 Coronary Artery Disease Progression in Patients With Acute Coronary Syndromes and Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03890822 Recruiting Humanitas Hospital, Italy 2022-03-25
NCT03852082 Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention https://ClinicalTrials.gov/show/NCT03852082 Recruiting Nanjing First Hospital, Nanjing Medical University 2020-04-30
NCT03782688 Precise Percutaneous Coronary Intervention Plan (P3) Study https://ClinicalTrials.gov/show/NCT03782688 Recruiting Onze Lieve Vrouw Hospital 2020-01-15
NCT03760705 Singapore Cardiac Longitudinal Outcomes Database https://ClinicalTrials.gov/show/NCT03760705 Active, not recruiting National Heart Centre Singapore 2025-12-31
NCT03691688 The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease(AURORA) https://ClinicalTrials.gov/show/NCT03691688 Recruiting Shanghai Zhongshan Hospital 2021-11-01
NCT03622203 Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent https://ClinicalTrials.gov/show/NCT03622203 Completed Azienda Ospedaliera Città della Salute e della Scienza di Torino 2018-01-31
NCT03518437 Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging https://ClinicalTrials.gov/show/NCT03518437 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2019-09-30
NCT03509532 DRUG ELUTING STENT FOR DIABETIC PATIENTS IN CORONARY ARTERY DISEASE TREATMENT https://ClinicalTrials.gov/show/NCT03509532 Recruiting Istituto Clinico Sant’Ambrogio 2019-01-31
NCT03462277 DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease https://ClinicalTrials.gov/show/NCT03462277 Completed Chongqing Medical University 2018-08-01
NCT03461367 CTO Registry From Insight of IVUS in Fuwai Hospital https://ClinicalTrials.gov/show/NCT03461367 Recruiting China National Center for Cardiovascular Diseases 2019-12-31
NCT03444259 Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients https://ClinicalTrials.gov/show/NCT03444259 Recruiting University of Turku 2025-12-31
NCT03443999 S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System https://ClinicalTrials.gov/show/NCT03443999 Recruiting Sahajanand Medical Technologies Pvt. Ltd. 2022-06-30
NCT03428048 Cardiovascular Innovation & Research Institute ’s NEXUS Registry, the Whole is Greater Than the Parts. https://ClinicalTrials.gov/show/NCT03428048 Recruiting Cardiovascular Innovation and Research Institute 2026-03-31
NCT04305171 Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers https://ClinicalTrials.gov/show/NCT04305171 Completed Mahidol University 2020-01-31
NCT02362659 Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry https://ClinicalTrials.gov/show/NCT02362659 Completed Icahn School of Medicine at Mount Sinai 2018-11-15
NCT03767621 Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR https://ClinicalTrials.gov/show/NCT03767621 Recruiting Fundación EPIC 2025-06-30
NCT03745066 BioFreedom French Registry https://ClinicalTrials.gov/show/NCT03745066 Active, not recruiting Biosensors Europe SA 2021-04-30
NCT02929030 Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease https://ClinicalTrials.gov/show/NCT02929030 Recruiting Xijing Hospital 2018-01-31
NCT02621216 Tilburg Health Outcomes Registry of Emotional Stress in Coronary Intervention https://ClinicalTrials.gov/show/NCT02621216 Recruiting University of Tilburg 2023-12-31